Autolus Therapeutics (AUTL) Revenue Growth (3y) (2020 - 2025)
Autolus Therapeutics (AUTL) Revenue Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - | - |
| 2 | Nanobiotix | 1,899.87 Bn | 1,899.81 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 470.43 Bn | 465.64 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 123.43 Bn | 116.19 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 70.20 Bn | 61.44 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 61.75 Bn | 61.75 Bn | - | - |
| 8 | Argenx Se | 56.15 Bn | 50.96 Bn | 1.41 Bn | 79.44% |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn | 54.05% |
| 10 | Autolus Therapeutics | 396.55 Mn | 95.84 Mn | -1.04 Mn | 87.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 87.94% |
| Sep 30, 2025 | 107.59% |
| Mar 31, 2025 | 278.23% |
| Mar 31, 2024 | 234.85% |
| Sep 30, 2023 | -2.50% |
| Mar 31, 2023 | 56.36% |
| Mar 31, 2022 | -56.11% |
| Sep 30, 2021 | -8.39% |
| Jun 30, 2021 | 20.14% |
| Dec 31, 2020 | 20.48% |